ID

13394

Description

Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT00712686

Lien

https://clinicaltrials.gov/show/NCT00712686

Mots-clés

  1. 10/02/2016 10/02/2016 -
Téléchargé le

10 février 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Schizophrenia NCT00712686

Eligibility Schizophrenia NCT00712686

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with dsm-iv diagnosis of schizophrenia patients in acute relapse
Description

schizophrenia relapse

Type de données

boolean

Alias
UMLS CUI [1,1]
C0036341
UMLS CUI [1,2]
C0277556
treated as outpatients for at least one continuous 3-month period during the past 12 months
Description

outpatients

Type de données

boolean

Alias
UMLS CUI [1]
C0029921
panss total score ≥60
Description

panss score

Type de données

boolean

Alias
UMLS CUI [1]
C0451383
previously responsive to neuroleptics (other than clozapine)
Description

neuroleptics

Type de données

boolean

Alias
UMLS CUI [1]
C0040615
able to give informed consent and comprehend and satisfactorily comply with the protocol requirements
Description

informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
an axis i (dsm-iv) diagnosis of schizoaffective disorder
Description

schizoaffective disorder

Type de données

boolean

Alias
UMLS CUI [1]
C0036337
a clinical picture and/or history that was consistent with: (a) delirium, dementia, amnestic or other cognitive disorders; (b) bipolar disorder; (c)personality disorder
Description

mental disorders

Type de données

boolean

Alias
UMLS CUI [1]
C0004936
nonresponsive to prior olanzapine therapy
Description

olanzapine response

Type de données

boolean

Alias
UMLS CUI [1,1]
C0171023
UMLS CUI [1,2]
C1704632
likely to require prohibited concomitant therapy
Description

therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0087111
dsm-iv criteria for any significant substance abuse within the past three months, including addiction to cocaine or alcohol
Description

substance abuse

Type de données

boolean

Alias
UMLS CUI [1]
C0038586
known to be allergic or hypersensitive to study drugs
Description

hypersensitivity

Type de données

boolean

Alias
UMLS CUI [1]
C0020517
represented a significant risk of committing suicide based on history or mental status exam
Description

suicidal

Type de données

boolean

Alias
UMLS CUI [1]
C0438696
unstable thyroid pathology and treatment within the past six months
Description

thyroid disease

Type de données

boolean

Alias
UMLS CUI [1]
C0040128
a history or evidence of a medical condition that would expose the patient to an undue risk
Description

comorbidity

Type de données

boolean

Alias
UMLS CUI [1]
C0009488
clinically significant abnormal laboratory test results (including urine drug screen), vital sign, or ecg findings
Description

health status

Type de données

boolean

Alias
UMLS CUI [1]
C0018759

Similar models

Eligibility Schizophrenia NCT00712686

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
schizophrenia relapse
Item
patients with dsm-iv diagnosis of schizophrenia patients in acute relapse
boolean
C0036341 (UMLS CUI [1,1])
C0277556 (UMLS CUI [1,2])
outpatients
Item
treated as outpatients for at least one continuous 3-month period during the past 12 months
boolean
C0029921 (UMLS CUI [1])
panss score
Item
panss total score ≥60
boolean
C0451383 (UMLS CUI [1])
neuroleptics
Item
previously responsive to neuroleptics (other than clozapine)
boolean
C0040615 (UMLS CUI [1])
informed consent
Item
able to give informed consent and comprehend and satisfactorily comply with the protocol requirements
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
schizoaffective disorder
Item
an axis i (dsm-iv) diagnosis of schizoaffective disorder
boolean
C0036337 (UMLS CUI [1])
mental disorders
Item
a clinical picture and/or history that was consistent with: (a) delirium, dementia, amnestic or other cognitive disorders; (b) bipolar disorder; (c)personality disorder
boolean
C0004936 (UMLS CUI [1])
olanzapine response
Item
nonresponsive to prior olanzapine therapy
boolean
C0171023 (UMLS CUI [1,1])
C1704632 (UMLS CUI [1,2])
therapy
Item
likely to require prohibited concomitant therapy
boolean
C0087111 (UMLS CUI [1])
substance abuse
Item
dsm-iv criteria for any significant substance abuse within the past three months, including addiction to cocaine or alcohol
boolean
C0038586 (UMLS CUI [1])
hypersensitivity
Item
known to be allergic or hypersensitive to study drugs
boolean
C0020517 (UMLS CUI [1])
suicidal
Item
represented a significant risk of committing suicide based on history or mental status exam
boolean
C0438696 (UMLS CUI [1])
thyroid disease
Item
unstable thyroid pathology and treatment within the past six months
boolean
C0040128 (UMLS CUI [1])
comorbidity
Item
a history or evidence of a medical condition that would expose the patient to an undue risk
boolean
C0009488 (UMLS CUI [1])
health status
Item
clinically significant abnormal laboratory test results (including urine drug screen), vital sign, or ecg findings
boolean
C0018759 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial